TCL Archive Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women November 26, 2010
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed October 8, 1976